Insulet (PODD) announced positive clinical trial results for its next-generation tubeless Omnipod 6 Automated Insulin Delivery (AID) System. The data supports the system's efficacy and safety, potentially boosting its market position.
Insulet Reports Positive Clinical Trial Data for Omnipod 6 AID System
PODDInsuletMedical DevicesClinical TrialsHealthcare



